Cellular and Molecular Life SciencesGenomicsPeer-reviewed journal article
An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast Cancer
Carolina Di BenedettoiD, Amelia Tsark, Daniza Diane Acenas, Alysia Thach, Anmol Singhal, Valentina Opazo-Mellado, Anthony Rodriguez-Lemus, Mustapha El Zeini, Hui ZhangiD, Catherine ParkiD, Hugo González VelozoiD, Irving L. WeissmaniD, Paola A. BetancuriD
Abstract
Highly accessible genomic super-enhancers often drive tumor-promoting programs, yet the impact of genomic variation within these regulatory elements remains unclear. Here, we identified a bifunctional super-enhancer that regulates the expression of cancer-promoting genes LINC00636 and CD47 in breast cancer. We discovered that a common germline insertion variant within the super-enhancer is associated with reduced chromatin accessibility at the super-enhancer locus. Deletion of the insertion in breast cancer cells increased chromatin accessibility, leading to upregulation of LINC00636 and CD47, enhanced resistance to nutrient-deprivation-induced apoptosis (mediated by CD47), activation of senescence (driven by elevated LINC00636), delayed cell death, and reduced infiltration of CD80 pro-inflammatory macrophages, changes that represent tumor-promoting features. Together, our findings uncover a common insertion-deletion variant that fine-tunes the regulatory activity of a bifunctional super-enhancer, suggest a protective role for the insertion allele, and establish a novel function for LINC00636 in senescence and breast cancer.
- organism: human
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: variant effect prediction
- approach: statistical model
- approach: experimental assay
- Citations
- 1
- FWCI
- 3.22
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes
Yihan Wang, Daniel A. Armendariz, … Gary C. Hon·Genome biologyPeer-reviewed·Jan 17, 2025
- Super-enhancer driven expression of BAHCC1 promotes melanomacell proliferation and genome stability
P. Berico, M. Nogaret, … F. Coin·bioRxiv·Jan 18, 2023
- Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype
Camila D. Arcuschin, Kamin Kahrizi, … Denise P. Muñoz·Cellular and Molecular Life SciencesPeer-reviewed·Nov 13, 2025
- PARP1 Regulates 3D Structure and Function of Super-Enhancers and Hormone-Control Regions in Breast Cancer Cells
Houda Baccara, François Le Dily, … Roberto Ferrari·bioRxiv·Aug 1, 2025
- NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast Cancer
C. Di Benedetto, J. Oh, … P. Betancur·bioRxiv·Apr 1, 2022
- Mediator Subunit Med4 Enforces Metastatic Dormancy in Breast Cancer
S.-Y. Bae, H.-H. Ling, … F. G. Giancotti·bioRxiv·Nov 18, 2023